A Randomized Trial of Ixempra Versus Taxol in Adjuvant Therapy of Triple Negative Breast Cancer - No Study Results Posted

A Randomized Trial of Ixempra Versus Taxol in Adjuvant Therapy of Triple Negative Breast Cancer (TITAN)

This study is ongoing, but not recruiting participants.

Study NCT00789581 Information provided by Sarah Cannon Research Institute

First Received: November 11, 2008 Last Updated: February 17, 2011 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study is ongoing, but not recruiting participants.
Estimated Study Completion Date:	January 2016
Estimated Primary Completion Date:	January 2015 (Final data collection date for primary outcome measure)